Searched for
INDIA US DRUG TRADE
Explained: What Donald Trump's up to 200% pharma tariffs mean for Indian investorsDonald Trump's announcement of tariffs of up to 200% on pharmaceutical imports triggered a selloff in Indian pharma stocks. However, analys...- Indian pharma firms may yet survive Trump's 200% tariff bombshellDonald Trump's proposed up to 200% tariff on generic drug imports has raised concerns for Indian pharma companies, but industry experts say...
- 200% Trump tariff shock? India’s cheap pills may still beat US rivalsUS President Donald Trump's proposed tariffs of up to 200% on imported generic medicines could put pressure on India's pharmaceutical expor...
- Trump’s 100% generic drug duty threatens US low-cost supplyPresident Donald Trump has given generic drugmakers two years to shift manufacturing to the US or face 100% import tariffs from August 2028...
- Trump's 200% drug tariff plan: Is India's pharma industry about to face an economic storm?The United States is set to implement a phased approach to tariffs on generic drug imports, beginning at zero percent and escalating to one...
- Trump announces new generic drugs tariff plan: No tariffs for 2 years, then 100%, and then 200%For Indian exporters, the two-year tariff-free period offers additional time to reassess supply chains and investment plans. While the imme...
- Sun Pharma, Cipla & other pharma stocks shed over 2% as Trump announces up to 200% tariffs on generic drugs from 2028Pharma stocks, including Sun Pharma, Cipla, Lupin and Dr Reddy's, fell up to 2.5% after US President Donald Trump announced a phased tariff...
- Trump tariffs may stay alive as US set to impose new import taxes by FridayDonald Trump is likely planning new import duties on many nations by Friday. These levies aim to continue his tariff regime after current o...
- Venezuela's Maduro, US propose June 2027 start for drug trafficking trialVenezuelan President Nicolas Maduro and US prosecutors proposed a June 2027 trial date. This joint proposal came ahead of a scheduled court...
- India engaged with the US, studying all the developments: Govt tells ParliamentThe government told Parliament it is closely monitoring developments in its trade relationship with the US and remains engaged with Washing...
- Natco Pharma shares surge 5% after US FDA's tentative nod Olaparib tabletsNatco Pharma shares rose sharply on Monday after the U.S. FDA granted tentative approval for its generic Olaparib tablets, a bioequivalent ...
- ASEAN, Africa lead India's export growth in first two months of FY27ASEAN and Africa were the biggest drivers of India's export growth in the first two months of FY27, with exports to ASEAN surging 66.9% to ...
- Novo Nordisk's obesity drug Wegovy wins India approval to fight silent fatty liver killerIndia's drug regulator approved Novo Nordisk's Wegovy for MASH treatment. This drug targets a serious progressive form of fatty liver disea...
- US Senate bill seeks 100% tariffs on India, 4 other nations for buying Russian oilA bipartisan bill introduced in the US Senate proposes 100% tariffs on imports from the top five buyers of Russian oil or gas, including In...
- Pharma exports to UK may rise up to 10% in FY27 as CETA takes effectIndia's pharmaceutical exports to the UK are set to witness substantial growth thanks to the recently negotiated Comprehensive Economic and...
- Merck gets US FDA nod for first-in-its-class oral cholesterol drugThe U.S. FDA has approved Merck's new cholesterol-lowering pill, Lipfendra. This oral medication works by blocking the PCSK9 protein, which...
- India-UK FTA projected to boost Indian pharma exports by over 8% to $981 million in FY27: PharmexcilIndian pharmaceutical exports to the United Kingdom are projected to grow significantly. The India-UK Comprehensive Economic and Trade Agre...
- FDA approves at-home starter dose of Eisai-Biogen Alzheimer's drugThe US FDA approved an at-home starting dose for Eisai and Biogen's Alzheimer's drug. This new subcutaneous formulation allows patients to ...
- 'False, baseless': Piyush Goyal pushes back on India-US trade deal claimsCommerce Minister Piyush Goyal has dismissed reports that India rejected a quick trade deal with the US as "completely false, baseless and ...
- Assam is key transit route for Myanmar drugs, says CM Himanta Biswa SarmaAssam is a key transit route for illegal drugs originating from Myanmar, CM Himanta Biswa Sarma said. Drug peddlers often use women and chi...
Load More
